US Plans Ebola Facility in Kenya Faces Backlash

On June 2, 2026, Oz mentioned that the U.S. has a “well-constructed game plan” led by Dr. Jay Bhattacharya from the National Institute of Health, which is actively funding treatments for the disease in Africa.

He also defended the controversial proposal to establish a 50-bed facility in Kenya for Americans exposed to the virus, despite facing significant criticism locally. “Sending patients from Africa back across the world isn’t the smartest approach,” he told reporters during a White House briefing.

Meanwhile, the Kenyan High Court extended its previous order to halt construction of the facility located near Nanyuki for another three weeks.

At Laikipia Airbase, where the facility is slated to be built, there was a shooting incident resulting in one death at the hospital, according to the BBC. Initial reports indicated another victim was also deceased upon arrival.

Details surrounding the shootings are still murky. Protest organizers claimed the shootings occurred after police fired on demonstrators; however, a spokesperson from the Kenyan police denied being aware of any fatalities.

Kenyan President William Ruto came to the defense of the proposed facility, calling it part of a “wider national preparedness initiative.” He has stated that it would also be beneficial for Kenyans.

Currently, the Democratic Republic of Congo has reported 321 confirmed cases of Ebola, as noted in a WHO update, which also highlighted 116 suspected cases—down from over 1,100 previous suspected cases, as indicated by the Africa CDC.

Patients whose conditions were ruled out had either other illnesses or only showed fever-like symptoms, WHO spokesperson Christian Lindmeier explained.

The outbreak has led to at least 48 deaths, with only six recoveries reported in central Africa.

In Uganda, six additional cases of Ebola were confirmed, bringing the nation’s total to 15. Authorities are currently monitoring 668 people known to be in contact with confirmed cases.

So far, Uganda has experienced only one death from this outbreak, with 12 individuals still hospitalized and two having been discharged.

On June 1, 2026, CEPI announced it would distribute funds to Moderna, researchers at the University of Oxford, and the International AIDS Vaccine Initiative. They are all collaborating on new Ebola vaccines that might be ready for clinical trials soon.

A patient who traveled from Congo to Italy with symptoms similar to Ebola has tested negative for the disease, part of a broader concern involving three travelers exhibiting symptoms in Italy and Brazil.

In Kenya, protests erupted against the U.S. construction of the Ebola facility, with local leaders expressing fears that it could expose the Kenyan populace to infection.

World Health Organization Director-General Tedros Ghebreyesus remarked that prompt medical attention increases the chances of survival for patients infected with the Bundibugyo variant, which currently lacks an approved vaccine or treatment.

On May 31, 2026, two patients suspected of having Ebola in Brazil tested positive for different conditions—one for meningitis and the other for malaria. Public health officials, however, cautioned that those results do not rule out possible Ebola infections.

The Africa CDC has reported more than 1,100 suspected cases of Ebola across multiple countries, with a death toll nearing 250.

Health officials continue stressing the need for global cooperation in the face of the escalating Ebola crisis and emphasize that this situation cannot be addressed by any single nation alone. Public health leaders are deeply concerned, stating that the outbreak is outpacing current response efforts.

A significant portion of the outbreak is linked to longstanding ethnic conflicts in the Ituri Province of the DRC, fueled by control over land and resources. This area, plagued by violence for decades, is now compounded by the rapid spread of the disease. The battle against Ebola is complicated by deep mistrust in local institutions and ongoing humanitarian issues.

Current efforts focus on supportive care for those infected, as the Bundibugyo strain of Ebola lacks an available vaccine or treatment. The WHO is exploring the possibility of utilizing existing vaccines developed for different strains as a potential safety measure. However, the overall response remains under scrutiny as the situation evolves.

There have been multiple incidences of violence at healthcare facilities treating Ebola patients, highlighting the strained relationship between communities and health authorities. The ongoing crisis is a reminder of the need for effective communication and solidarity in tackling public health emergencies.